Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
• 1.4 Market by Type
  • 1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Inhalable Insulin
  • 1.4.3 Oral Insulin
  • 1.4.4 Insulin Patches
  • 1.4.5 CGM Systems
  • 1.4.6 Artificial Pancreas
• 1.5 Market by Application
  • 1.5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostic/Clinics
  • 1.5.3 ICUs
  • 1.5.4 Home Healthcare
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2015-2026)
• 2.2 Global Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Regions
  • 2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Share by Regions (2015-2020)
  • 2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Next Generation Diabetes Therapy and Drug Delivery Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Next Generation Diabetes Therapy and Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Market Size
  • 3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2015-2020)
  • 3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
  • 3.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2019
• 3.3 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
• 3.4 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
• 3.5 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2015-2020)
• 4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
• 5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 6.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in North America (2019-2020)
• 6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 7.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Europe (2019-2020)
• 7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

8 China

• 8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 8.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in China (2019-2020)
• 8.3 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 8.4 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 9.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Japan (2019-2020)
• 9.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 9.4 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 10.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 10.4 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

11 India

• 11.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 11.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in India (2019-2020)
• 11.3 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 11.4 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
• 12.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
• 12.4 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Johnson & Johnson
  • 13.1.1 Johnson & Johnson Company Details
  • 13.1.2 Johnson & Johnson Business Overview
  • 13.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020))
  • 13.1.5 Johnson & Johnson Recent Development
• 13.2 Abbott Laboratories
  • 13.2.1 Abbott Laboratories Company Details
  • 13.2.2 Abbott Laboratories Business Overview
  • 13.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.2.5 Abbott Laboratories Recent Development
• 13.3 Medtronic
  • 13.3.1 Medtronic Company Details
  • 13.3.2 Medtronic Business Overview
  • 13.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.3.5 Medtronic Recent Development
• 13.4 Sanofi
  • 13.4.1 Sanofi Company Details
  • 13.4.2 Sanofi Business Overview
  • 13.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.4.5 Sanofi Recent Development
• 13.5 Novo Nordisk
  • 13.5.1 Novo Nordisk Company Details
  • 13.5.2 Novo Nordisk Business Overview
  • 13.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.5.5 Novo Nordisk Recent Development
• 13.6 MannKind Corporation
  • 13.6.1 MannKind Corporation Company Details
  • 13.6.2 MannKind Corporation Business Overview
  • 13.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.6.5 MannKind Corporation Recent Development
• 13.7 Enteris BioPharma
  • 13.7.1 Enteris BioPharma Company Details
  • 13.7.2 Enteris BioPharma Business Overview
  • 13.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.7.5 Enteris BioPharma Recent Development
• 13.8 Dexcom
  • 13.8.1 Dexcom Company Details
  • 13.8.2 Dexcom Business Overview
  • 13.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.8.5 Dexcom Recent Development
• 13.9 Senseonics
  • 13.9.1 Senseonics Company Details
  • 13.9.2 Senseonics Business Overview
  • 13.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.9.5 Senseonics Recent Development
• 13.10 Medtech
  • 13.10.1 Medtech Company Details
  • 13.10.2 Medtech Business Overview
  • 13.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 13.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 13.10.5 Medtech Recent Development
• 13.11 Synertech
  • 10.11.1 Synertech Company Details
  • 10.11.2 Synertech Business Overview
  • 10.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 10.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 10.11.5 Synertech Recent Development
• 13.12 Zosano Pharma
  • 10.12.1 Zosano Pharma Company Details
  • 10.12.2 Zosano Pharma Business Overview
  • 10.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 10.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 10.12.5 Zosano Pharma Recent Development
• 13.13 Relmada Therapeutics
  • 10.13.1 Relmada Therapeutics Company Details
  • 10.13.2 Relmada Therapeutics Business Overview
  • 10.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 10.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 10.13.5 Relmada Therapeutics Recent Development
• 13.14 Eli Lilly and Company
  • 10.14.1 Eli Lilly and Company Company Details
  • 10.14.2 Eli Lilly and Company Business Overview
  • 10.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 10.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 10.14.5 Eli Lilly and Company Recent Development
• 13.15 Transdermal Specialties
  • 10.15.1 Transdermal Specialties Company Details
  • 10.15.2 Transdermal Specialties Business Overview
  • 10.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
  • 10.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
  • 10.15.5 Transdermal Specialties Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer